Fragrance allergy and quality of life - Development and validation of a disease-specific quality of life instrument

Contact Dermatitis

Volumn 70, Issue 2, 2014, Pages 69-80

  Heisterberg, Maria V ^a   Menné, Torkil ^a   Johansen, Jeanne D ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

allergic contact dermatitis; allergy; development of disease specific questionnaire; DLQI; FQL index; fragrance; fragrance QoL index; perfume; quality of life; SF36; validation of questionnaire

Indexed keywords

FRAGRANCE;

ADULT; AGED; ARTICLE; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; ECZEMA; FEMALE; FRAGRANCE ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; QUALITY OF LIFE; QUALITY OF LIFE INDEX; RELIABILITY; SCORING SYSTEM; SHORT FORM 36; SKIN ALLERGY; UNIVERSITY HOSPITAL; YOUNG ADULT;

ADULT; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; PERFUME; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84892929879     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/cod.12153     Document Type: Article

References (43)

1. Heisterberg M V, Andersen K E, Avnstorp C, et al. Fragrance mix II in the baseline series contributes significantly to detection of fragrance allergy. Contact Dermatitis 2010: 63: 270-276.
2. Nardelli A, Carbonez A, Ottoy W, Drieghe J, Goossens A,. Frequency of and trends in fragrance allergy over a 15-year period. Contact Dermatitis 2008: 58: 134-141.
3. Schnuch A, Geier J, Uter W, et al. National rates and regional differences in sensitization to allergens of the standard series. Population-adjusted frequencies of sensitization (PAFS) in 40,000 patients from a multicenter study (IVDK). Contact Dermatitis 1997: 37: 200-209.
4. Lysdal S H, Johansen J D,. Fragrance contact allergic patients: strategies for use of cosmetic products and perceived impact on life situation. Contact Dermatitis 2009: 61: 320-324.
5. Holm E A, Wulf H C, Stegmann H, Jemec G B,. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006: 154: 719-725.
6. Meding B, Wrangsjö K, Jarvholm B,. Fifteen-year follow-up of hand eczema: persistence and consequences. Br J Dermatol 2005: 152: 975-980.
7. Moberg C, Alderling M, Meding B,. Hand eczema and quality of life: a population-based study. Br J Dermatol 2009: 161: 397-403.
8. Wallenhammar L M, Nyfjall M, Lindberg M, Meding B,. Health-related quality of life and hand eczema-a comparison of two instruments, including factor analysis. J Invest Dermatol 2004: 122: 1381-1389.
9. Benyamini Y, Goner-Shilo D, Lazarov A,. Illness perception and quality of life in patients with contact dermatitis. Contact Dermatitis 2012: 67: 193-199.
10. Coghi S, Bortoletto M C, Sampaio S A, Andrade Junior H F, Aoki V,. Quality of life is severely compromised in adult patients with atopic dermatitis in Brazil, especially due to mental components. Clinics (Sao Paulo) 2007: 62: 235-242.
11. Thomson K F, Wilkinson S M, Sommer S, Pollock B,. Eczema: quality of life by body site and the effect of patch testing. Br J Dermatol 2002: 146: 627-630.
12. Agner T, Andersen K E, Brandão F M, et al. Contact sensitisation in hand eczema patients-relation to subdiagnosis, severity and quality of life: a multi-centre study. Contact Dermatitis 2009: 61: 291-296.
13. Holness D L,. Results of a quality of life questionnaire in a patch test clinic population. Contact Dermatitis 2001: 44: 80-84.
14. Aaronson N K,. Quantitative issues in health-related quality of life assessment. Health Policy 1988: 10: 217-230.
15. Rapp S R, Feldman S R, Graham G, Fleischer A B, Brenes G, Dailey M,. The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument. Am J Clin Dermatol 2006: 7: 185-192.
16. McKenna S P, Lebwohl M, Kahler K N,. Development of the US PSORIQoL: a psoriasis-specific measure of quality of life. Int J Dermatol 2005: 44: 462-469.
17. Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005: 60: 1073-1078.
18. Anderson R T, Rajagopalan R,. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997: 37: 41-50.
19. Bracken B A, Barona A,. State of the art procedures for translating, validating and using phychoeducational tests in cross-cultural assessment. Sch Psychol Int 1991: 12: 119-132.
20. Finlay A Y, Khan G K,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994: 19: 210-216.
21. Herd R M, Tidman M J, Ruta D A, Hunter J A,. Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods. Br J Dermatol 1997: 136: 502-507.
22. Zachariae R, Zachariae C, Ibsen H, Mortensen J T, Wulf H C,. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000: 80: 272-276.
23. Ware J E Jr, Gandek B, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998: 51: 1167-1170.
24. Wagner A K, Gandek B, Aaronson N K, et al. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998: 51: 925-932.
25. Ware J E Jr, Kosinski M, Gandek B, et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998: 51: 1159-1165.
26. Bjorner J B, Damsgaard M T, Watt T, Groenvold M,. Tests of data quality, scaling assumptions, and reliability of the Danish SF-36. J Clin Epidemiol 1998: 51: 1001-1011.
27. Bjorner J B, Thunedborg K, Kristensen T S, Modvig J, Bech P,. The Danish SF-36 Health Survey: translation and preliminary validity studies. J Clin Epidemiol 1998: 51: 991-999.
28. Bjorner J B, Kreiner S, Ware J E, Damsgaard M T, Bech P,. Differential item functioning in the Danish translation of the SF-36. J Clin Epidemiol 1998: 51: 1189-1202.
29. Hays R D, Hadorn D,. Responsiveness to change: an aspect of validity, not a separate dimension. Qual Life Res 1992: 1: 73-75.
30. Shrout P E, Fleiss J L,. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979: 86: 420-428.
31. Wahlberg J E,. Identification of new allergens and non-irritant patch test preparations. Contact Dermatitis 1998: 39: 155-156.
32. Wilkinson D S, Fregert S, Magnusson B, et al. Terminology of contact dermatitis. Acta Derm Venereol 1970: 50: 287-292.
33. The European Commission. Consolidated version of Cosmetics Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products, Cosmetic Restriction III/I, 2005. 79. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1976L0768: 20100301:en:PDF (last accessed 10 June 2012).
34. Altman D G, Bland J M,. Measurement in medicine: the analysis of method comparison studies. Statistician 1983: 32: 307-317.
35. Boehm D, Schmid-Ott G, Finkeldey F, John S M, Dwinger C, Werfel T, Diepgen T L, Breuer K,. Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermatitis 2012: 67: 184-192.
36. Hutchings C V, Shum K W, Gawkrodger D J,. Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis 2001: 45: 17-20.
37. Twiss J, Meads D M, Preston E P, Crawford S R, McKenna S P,. Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? J Invest Dermatol 2012: 132: 76-84.
38. Lau M Y, Matheson M C, Burgess J A, Dharmage S C, Nixon R,. Disease severity and quality of life in a follow-up study of patients with occupational contact dermatitis. Contact Dermatitis 2011: 65: 138-145.
39. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M,. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000: 80: 430-434.
40. Jiamton S, Tangjaturonrusamee C, Kulthanan K,. Clinical features and aggravating factors in nummular eczema in Thais. Asian Pac J Allergy Immunol 2013: 31: 36-42.
41. Cvetkovski R S, Zachariae R, Jensen H, Olsen J, Johansen J D, Agner T,. Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis 2006: 54: 106-111.
42. Rajagopalan R, Kallal J E, Fowler J F Jr, Sherertz E F,. A retrospective evaluation of patch testing in patients diagnosed with allergic contact dermatitis. Cutis 1996: 57: 360-364.
43. Chen Y C, Wu C S, Lu Y W, Li W C, Ko Y C, Yu H S, Chen G S, Lan C C,. Atopic dermatitis and non-atopic hand eczema have similar negative impacts on quality of life: implications for clinical significance. Acta Derm Venereol 2013: 65: 22-27.